Sunscreen slow down: The US FDA's sluggish approval of new sunscreens frustrates physicians, manufacturers, and consumers

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0142|121|17|2861-2862

ISSN： 0008-543x

Source： CANCER, Vol.121, Iss.17, 2015-09, pp. : 2861-2862

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ticagrelor FDA Approval Issues Revisited

By  

Cardiology, Vol. 122, Iss. 3, 2012-07 ,pp. : 144-147

Karger

Access to resources Recommend Favorite

Vireo to to seek FDA approval for nonsmokeable cannabis

By  

ALCOHOLISM AND DRUG ABUSE WEEKLY, Vol. 27, Iss. 47, 2015-12 ,pp. : 4-5

John Wiley & Sons Inc

Access to resources Recommend Favorite

Generic drug approval: A US perspective

By Nagori B.P.   Mathur V.   Garg S.  

Current Medical Research and Opinion, Vol. 27, Iss. 3, 2011-03 ,pp. : 541-545

Informa Healthcare

Access to resources Recommend Favorite

New Drugs Accepted by the FDA

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 12, Iss. 8, 1964-08 ,pp. : 811-811

John Wiley & Sons Inc

Access to resources Recommend Favorite

Water‐resistant sunscreens for skin protection: an in vivo approach to the two sources of sunscreen failure to maintain UV protection on consumer skin

By  

INTERNATIONAL JOURNAL OF COSMETIC SCIENCE, Vol. 37, Iss. 6, 2015-12 ,pp. : 613-619

John Wiley & Sons Inc

Access to resources Recommend Favorite